Skip to Main Content

Paper Details

Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.
Nat Commun
36
2021
LMD, Leptomeningeal disease, anorexia, colitis, fatigue, fever, hepatitis, ipilimumab, leptomeningeal carcinomatosis, nausea, patients, rash, solid tumor malignancies
Author NameAffiliation
Priscilla K BrastianosMassachusetts General Hospital
Nancy WangMassachusetts General Hospital
Nancy U LinDana-Farber Cancer Institute
Aditya BardiaMassachusetts General Hospital
Brian V NahedMassachusetts General Hospital
Helen A ShihMassachusetts General Hospital
Scott L CarterDana-Farber Cancer Institute
  • 1 - 7

Datasets

Release 1.2